These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6591877)

  • 1. Clinical varieties of neuromuscular disease in debrancher deficiency.
    Cornelio F; Bresolin N; Singer PA; DiMauro S; Rowland LP
    Arch Neurol; 1984 Oct; 41(10):1027-32. PubMed ID: 6591877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Debrancher deficiency: neuromuscular disorder in 5 adults.
    DiMauro S; Hartwig GB; Hays A; Eastwood AB; Franco R; Olarte M; Chang M; Roses AD; Fetell M; Schoenfeldt RS; Stern LZ
    Ann Neurol; 1979 May; 5(5):422-36. PubMed ID: 288318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nine cases of debrancher deficiency (glycogen storage disease type III) presenting muscle weakness--study on clinicobiochemical analysis].
    Fukuda T; Sugie H; Ito M; Tsurui S; Sugie Y; Igarashi Y
    Rinsho Shinkeigaku; 1996 Apr; 36(4):540-3. PubMed ID: 8810846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen Debrancher Enzyme Deficiency Myopathy.
    Sadeh M; Yosovich K; Dabby R
    J Clin Neuromuscul Dis; 2021 Jun; 22(4):224-227. PubMed ID: 34019008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The electrodiagnostic characteristics of Glycogen Storage Disease Type III.
    Hobson-Webb LD; Austin SL; Bali DS; Kishnani PS
    Genet Med; 2010 Jul; 12(7):440-5. PubMed ID: 20071996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different clinical aspects of debrancher deficiency myopathy.
    Kiechl S; Kohlendorfer U; Thaler C; Skladal D; Jaksch M; Obermaier-Kusser B; Willeit J
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):364-8. PubMed ID: 10449560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myopathy in debrancher enzyme deficiency.
    Winterer J
    J Pediatr; 1985 Aug; 107(2):313-4. PubMed ID: 3860636
    [No Abstract]   [Full Text] [Related]  

  • 8. Myopathies due to enzyme deficiencies.
    Cornelio F; Di Donato S
    J Neurol; 1985; 232(6):329-40. PubMed ID: 2934518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid maltase deficiency and related myopathies.
    Amato AA
    Neurol Clin; 2000 Feb; 18(1):151-65. PubMed ID: 10658172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological characteristics of glycogen storage disease III in skeletal muscle.
    Gershen LD; Prayson BE; Prayson RA
    J Clin Neurosci; 2015 Oct; 22(10):1674-5. PubMed ID: 26067541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy.
    Coleman RA; Winter HS; Wolf B; Gilchrist JM; Chen YT
    Ann Intern Med; 1992 Jun; 116(11):896-900. PubMed ID: 1580445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysis.
    Duboc D; Jehenson P; Tran Dinh S; Marsac C; Syrota A; Fardeau M
    Neurology; 1987 Apr; 37(4):663-71. PubMed ID: 2951614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory diagnosis of the neuromuscular glycogen storage diseases.
    Farmer PM
    Ann Clin Lab Sci; 1982; 12(6):431-8. PubMed ID: 6817693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen storage myopathies.
    Tsujino S; Nonaka I; DiMauro S
    Neurol Clin; 2000 Feb; 18(1):125-50. PubMed ID: 10658171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein nocturnal enteral therapy.
    Slonim AE; Coleman RA; Moses WS
    J Pediatr; 1984 Dec; 105(6):906-11. PubMed ID: 6438290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GYG1 causing progressive limb girdle myopathy with onset during teenage years (polyglucosan body myopathy 2).
    Desikan M; Scalco RS; Manole A; Gardiner AR; Schapira AH; Lachmann RH; Houlden H; Holton JL; Phadke R; Quinlivan R
    Neuromuscul Disord; 2018 Apr; 28(4):346-349. PubMed ID: 29422440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A 21-year-old man with distal dominant progressive muscle atrophy].
    Hattori Y; Nohara C; Hirasawa E; Mori H; Imai H; Mizuno Y
    No To Shinkei; 1995 May; 47(5):509-18. PubMed ID: 7786629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle phosphofructokinase deficiency: abnormal polysaccharide in a case of late-onset myopathy.
    Hays AP; Hallett M; Delfs J; Morris J; Sotrel A; Shevchuk MM; DiMauro S
    Neurology; 1981 Sep; 31(9):1077-86. PubMed ID: 6943439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible severe myopathy of respiratory muscles due to adult-onset type III glycogenosis.
    Kiechl S; Willeit J; Vogel W; Kohlendorfer U; Poewe W
    Neuromuscul Disord; 1999 Oct; 9(6-7):408-10. PubMed ID: 10545045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of debrancher deficiency myopathy by the use of high-protein nutrition.
    Slonim AE; Weisberg C; Benke P; Evans OB; Burr IM
    Ann Neurol; 1982 Apr; 11(4):420-2. PubMed ID: 7049057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.